Decreased levels of β-endorphin in circulating mononuclear leukocytes from patients with acute myocardial infarction

Cardiology

Volumn 90, Issue 1, 1998, Pages 43-47

  Buratti, Thomas ^a   Schratzberger, Peter ^a   Dunzendorfer, Stefan ^a   Manfreda, Susanne E ^a   Pechlaner, Christoph ^a   Joannidis, Michael ^a   Sacerdote, Paula ^b   Panerai, Alberto E ^b   Wiedermann, Christian J ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Acute myocardial infarction; C reactive protein; Immunoreactive endorphin; Leukocytes

Indexed keywords

ACUTE PHASE PROTEIN; BETA ENDORPHIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CELL LEVEL; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; MALE; MONOCYTE; MONONUCLEAR CELL; PAIN; PRIORITY JOURNAL; STRESS;

BETA-ENDORPHIN; C-REACTIVE PROTEIN; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 0031821850     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000006815     Document Type: Article

References (55)

1. Heijnen CJ, Kavelaars A, Ballieux RE: Beta-endorphin: Cytokine and neuropeptide. Immunol Rev 1991;119:41-63.
2. Buzzetti R, McLoughlin L, Lavender PM, Clark AJ, Rees LH: Expression of pro-opiomelanocortin gene and quantification of adreno-corticotropic hormone-like immunoreactivity in human normal peripheral mononuclear cells and lymphoid and myeloid malignancies. J Clin Invest 1989;83:733-737.
3. Stephanou A, Fitzharris P, Knight RA, Lightman SL: Characteristics and kinetics of pro-opiomelanocortin mRNA expression by human leucocytes. Brain Behav Immun 1991;5: 319-327.
4. Mechanick JI, Levin N, Roberts JL, Autelitano DJ: Proopiomelanocortin gene expression in a distinct population of rat spleen and lung leucocytes. Endocrinology 1992;131:518-525.
5. Ottaviani E, Capriglione T, Franceschini C: Invertebrate and vertebrate immune cells express pro-opiomelanocortin (POMC) mRNA. Brain Behav Immun 1995;9:1-8.
6. Smith EM, Blalock JE: Human lymphocyte production of corticotropin and endorphin-like substances: Association with leukocyte interferon. Proc Natl Acad Sci USA 1981;78:7530-7534.
7. Pepper GM, Maimon J, Schneider BS: Quantification and characterization of ACTH-related peptides produced by human peripheral blood mononuclear cells. Lymphokine Cytokine Res 1991;10:133-140.
8. Lyons PD, Blalock JE: The kinetics of ACTH expression in rat leukocyte subpopulation. J Neuroimmunol 1995;63:103-112.
9. Harbour DV, Smith EM, Blalock JE: Splenic lymphocyte production of an endorphin during endotoxic shock. Brain Behav Immun 1987;1: 123-133.
10. van Woudenberg AD, Hol EM, Wiegant VM: Endorphin-like immunoreactivities in uncultured and cultured human peripheral blood mononuclear cells. Life Sci 1992;50:705-714.
11. Tuggle DW, Horton JW: Cardiocirculatory effects of physiological doses of beta-endorphin. Circ Shock 1986;18:215-225.
12. Maslow LN, Lishmanov YB: Change in opioid peptide level in the heart and blood plasma during acute myocardial ischemia complicated by ventricular fibrillation. Clin Exp Pharmacol Physiol 1995;22:812-816.
13. Fagbemi O, Lepran I, Parratt JR, Szekeres L: Naloxone inhibits early arrhythmias resulting from acute coronary ligation. Br J Pharmacol 1982;76:504-506.
14. Bernardi P, Fontana F, Pich EM, Spampinato S, Canossa M: Plasma endogenous opioid levels in acute myocardial infarction patients, with and without pain. Eur Heart J 1992; 13: 1074-1079.
15. Bach FW, Fahrenkrug J, Jensen K, Dahlstrom G, Ekman R: Plasma beta-endorphin during clinical and experimental ischemic pain. Scand J Clin Lab Invest 1987;47:751-758.
16. Heller GV, Garber CE, Connolly MJ, Allen-Rowlands CF, Siconolfi SF, Gann DS, Carleton RA: Plasma beta-endorphin levels in silent myocardial ischemia induced by exercise. Am J Cardiol 1987;59:735-739.
17. van Rijn T, Rabkin SW: Effect of naloxone on exercise-induced angina pectoris: A randomized double-blind crossover trial. Life Sci 1986; 38:609-615.
18. Marchant B, Umachandran V, Wilkinson P, Medbak S, Kopelman PG, Timmis AD: Reexamination of the role of endogenous opiates in silent myocardial ischemia. J Am Coll Cardiol 1994;23:645-651.
19. Ellestad MH, Kuan P: Naloxone and asymptomatic ischemia: Failure to induce angina during exercise testing. Am J Cardiol 1984;54: 982-984.
20. Panerai AE, Martini A, Di Giulio AM, Fraioli F, Vegni C, Pardi G, Marini A, Mantegazza P: Plasma beta-endorphin, beta-lipotropin and met-enkephalin concentrations during pregnancy in normal and drug-addicted women and their newborn. J Clin Endocrinol Metab 1983;57:537-542.
21. Harbour-McMenamin D, Smith EM, Blalock JE: Bacterial lipopolysaccharide induction of leukocyte-derived corticotropin and endorphins. Infect Immun 1985;48:813-817.
22. Smith EM, Morrill AC, Meyer WJ, Blalock JE: Corticotropin releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins. Nature 1986;321:881-882.
23. Sacerdote P, Bianchi M, Manfredi B, Panerai AE: Intracerebroventricular interleukin-1 alpha increases immunocyte beta-endorphin concentrations in the rat: Involvement of corticotropin releasing hormone, catecholamines, and serotonin. Endocrinology 1994;135:1346-1352.
24. Kavelaars A, Berkenbosch F, Croiset G, Ballieux RE, Heijnen CJ: Induction of beta-endorphin secretion by lymphocytes after subcutaneous administration of corticotropin-releasing factor. Endocrinology 1990;126:759-764.
25. Kavelaars A, Ballieux RE, Heijnen CJ: In vitro beta-adrenergic stimulation of lymphocytes induces the release of immunoreactive beta-endorphin. Endocrinology 1990:126:3028-3032.
26. Manfredi B, Clementi E, Sacerdote P, Bassetti M, Panerai AE: Age-related changes in mitogen-induced beta-endorphin release from human peripheral blood mononuclear cells. Peptides 1995;16:699-706.
27. Barcellini W, Sacerdote P, Borghi MO, Rizzardi GP, Fain C, De Giuli Morghen C, Manfredi B, Lazzarin A, Meroni PL, Panerai AE: Beta-endorphin content in HIV-infected HuT78 cell line and in peripheral lymphocytes from HIV-positive subjects. Peptides 1994;15:769-775.
28. Perricone R, Panerai AE; Sacerdote P, Moretti C, Pasetto N, de Carolis C, de Sanctis G, Fontana L: High amounts of beta-endorphin in peripheral blood mononuclear cells from HANE patients. Immunopharmacology 1991;22:21-25.
29. Leone M, Sacerdote P, D'Amico D, Panerai AE, Bussone G: Beta-endorphin levels are reduced in peripheral blood mononuclear cells of cluster headache patients. Cephalalgia 1993; 13:413-416.
30. Wiedermann CJ, Sacerdote P, Propst A, Propst T, Judmaier G, Kathrein H, Vogel W, Panerai AE: Decreased beta-endorphin content in peripheral blood mononuclear leukocytes from patients with Crohn's disease. Brain Behav Immun 1994;8:261-269.
31. Wiedermann CJ, Sacerdote P, Mur E, Kinigadner U, Wicker T, Panerai AE, Braunsteiner H: Decreased immunoreactive beta-endorphin in mononuclear leukocytes from patients with rheumatic diseases. Clin Exp Immunol 1992; 87:178-182.
32. Alexander RW: Inflammation and coronary artery disease. N Engl J Med 1994;331:468-469.
33. Thomson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC, for the European Concerted Action on Thrombosis and Disabilities Angina Group: Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1994;322: 635-641.
34. Pietilä KO, Harnoinen AP, Jokiniitty J, Pasternack AI: Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. Eur Heart J 1996;17:1345-1349.
35. Guillen I, Blanes M, Gomez Lechon MJ, Castell JV: Cytokine signalling during myocardial infarction: Sequential appearance of IL-1 beta and IL-6. Am J Physiol 1995;269:229-235.
36. Sturk A, Hack CE, Aarden LA, Brouver M, Koster RR, Sanders GT: Interleukin-6 release and the acute phase reaction in patients with acute myocardial infarction: A pilot study. J Lab Clin Med 1992;119:574-579.
37. Ikeda U, Ohkawa F, Seino Y, Yamamoto K, Hidaka Y, Kasahara T, Kawai T, Shimada K: Serum interleukin-6 levels become elevated in acute myocardial infarction. J Mol Cell Cardiol 1992;24:579-584.
38. Miyao Y, Yasue H, Ogawa H, Misumi I, Masuda T, Sakamoto T, Morita E: Elevated plasma interleukin-6 levels in patients with acute myocardial infarction. Am Heart J 1993;126:1299-1304.
39. Lippy P, Sukova G, Lee RT, Galis ZS: Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J Cardiovasc Pharmacol 1995;25(suppl 2):9-12.
40. Caliguri G, Summaria F, Liuzzo G, Rumi C, Grillo RL, Crea F, Rebuzzi AG, Biasucci LM, Maseri A: Time-course of T-lymphocyte activation and of C-reactive protein in unstable angina: Relation to prognosis. Circulation 1996;94:I-571.
41. Krieger DT: Brain peptides: What, where, and why. Science 1983;222:975-984.
42. Harbour DV, Smith EM: Immunoregulatory activity of endogenous opioids; in Frei S (ed): The Neuroendocrine-Immune Network. Boca Ranton, CRC Press, 1990, pp 141-161.
43. Wiedermann CJ, Schratzberger P, Kahler CM: Migration of neutrophils across endothelial monolayer is stimulated by treatment of the monolayers with beta endorphin. Brain Behav Immun 1994;8:270-277.
44. Muller WA: Migration of leukocytes across the vascular intima: Molecules and mechanisms. Trends Cardiovasc Med 1995;5:15-20.
45. Faden AI, Holaday JW: Opiate antagonists: A role in the treatment of hypovolemic shock. Science 1979;205:317-318.
46. Holaday JW, Faden AI: Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock. Nature 1978;275:450-451.
47. Harbour DV, Galin FS, Hughes TK, Smith EM, Blalock JE: Role of leukocyte derived proopiomelanocortin peptides in endotoxic shock. Circ Shock 1991;35:181-191.
48. Czlonkowski A, Stein C, Herz A: Peripheral mechanisms of opioid antinociception in inflammation: Involvement of cytokines. Eur J Pharmacol 1993;242:229-235.
49. Schafer M, Carter L, Stein C: Interleukin-1 beta and corticotropin releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc Natl Acad Sci USA 1994; 91:4219-4223.
50. Bergquist J, Tarkowski A, Ekman R, Ewing A: Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of leukocyte function via an autocrine loop. Proc Natl Acad Sci USA 1994;91: 12912-12916.
51. Cabot PJ, Carter L, Gaiddon C, Zhang Q, Schafer M, Loeffler JP, Stein C: Immune cell-derived beta-endorphin: Production, release, and control of inflammatory pain in rats. J Clin Invest 1997;100:142-148.
52. Glinski W, Brodecka H, Glinska Ferenz M, Kowalski D: Increased concentration of beta-endorphin in sera of patients with psoriasis and other inflammatory dermatoses. Br J Dermatol 1994;31:260-264.
53. Jessop DS, Renshaw D, Lighmann SL, Harbuz MS: Changes in ACTH and beta-endorphin immunoreactivity in immune tissues during chronic inflammatory stress are not correlated with changes in corticotropin-releasing hormone and arginine vasopressin. J Neuroimmunol 1995;60:29-35.
54. Schultz JE, Rose E, Yao Z, Gross GJ: Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol 1995;268:H2157-H2161.
55. Panerai AE, Sacerdote P: Beta-endorphin in the immune system: A role at last? Immunol Today 1997;18:317-319.